{"id":60987,"date":"2025-03-26T13:02:38","date_gmt":"2025-03-26T12:02:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/"},"modified":"2025-03-26T13:02:38","modified_gmt":"2025-03-26T12:02:38","slug":"bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/","title":{"rendered":"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30"},"content":{"rendered":"
\n

VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations<\/a> section of the Bausch + Lomb website prior to the start of the call.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nConference Call Details<\/b>\n<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\nDate:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\nWednesday, April 30, 2025\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nTime:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\n8 a.m. ET\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nWebcast:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\nhttps:\/\/www.webcaster4.com\/Webcast\/Page\/2883\/51713<\/a>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nParticipant Event Dial-in:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\n+1 (888) 506-0062 (North America)\n<\/p>\n

\n+1 (973) 528-0011 (International)\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nParticipant Access Code:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\n810276\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nReplay Dial-in:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\n+1 (877) 481-4010 (North America)\n<\/p>\n

\n+1 (919) 882-2331 (International)\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nReplay Passcode:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\n51713 (replay available until May 14, 2025)\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nAbout Bausch + Lomb<\/b>\n<\/p>\n

\nBausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world \u2013 from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com<\/a> and connect with us on X<\/a>, LinkedIn<\/a>, Facebook<\/a> and Instagram<\/a>.\n<\/p>\n

\n\u00a9 2025 Bausch + Lomb.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
Chris Clark
\n
chris.clark@bausch.com<\/a>
(848) 360-1100<\/p>\n

Investor Contact:<\/b>
George Gadkowski
\n
george.gadkowski@bausch.com<\/a>
(877) 354-3705 (toll free)\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-60987","format-standard","category-industry"],"yoast_head":"\nBausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-26T12:02:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250326073048\/en\/1668940\/22\/Bausch_Lomb_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30\",\"datePublished\":\"2025-03-26T12:02:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/\"},\"wordCount\":262,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250326073048\\\/en\\\/1668940\\\/22\\\/Bausch_Lomb_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/\",\"name\":\"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250326073048\\\/en\\\/1668940\\\/22\\\/Bausch_Lomb_logo.jpg\",\"datePublished\":\"2025-03-26T12:02:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250326073048\\\/en\\\/1668940\\\/22\\\/Bausch_Lomb_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250326073048\\\/en\\\/1668940\\\/22\\\/Bausch_Lomb_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/","og_locale":"en_US","og_type":"article","og_title":"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30 - Pharma Trend","og_description":"VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/","og_site_name":"Pharma Trend","article_published_time":"2025-03-26T12:02:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250326073048\/en\/1668940\/22\/Bausch_Lomb_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30","datePublished":"2025-03-26T12:02:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/"},"wordCount":262,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250326073048\/en\/1668940\/22\/Bausch_Lomb_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/","url":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/","name":"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250326073048\/en\/1668940\/22\/Bausch_Lomb_logo.jpg","datePublished":"2025-03-26T12:02:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250326073048\/en\/1668940\/22\/Bausch_Lomb_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250326073048\/en\/1668940\/22\/Bausch_Lomb_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bausch-lomb-will-release-first-quarter-2025-financial-results-on-april-30\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60987"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60987\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}